0001493152-26-027117.txt : 20260603 0001493152-26-027117.hdr.sgml : 20260603 20260603170017 ACCESSION NUMBER: 0001493152-26-027117 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 EFFECTIVENESS DATE: 20260603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 981034922 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586106 FILM NUMBER: 261061781 BUSINESS ADDRESS: STREET 1: 401 EAST JACKSON STREET STREET 2: SUITE 3300 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: (929) 274-7510 MAIL ADDRESS: STREET 1: 401 EAST JACKSON STREET STREET 2: SUITE 3300 CITY: TAMPA STATE: FL ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 D 1 primary_doc.xml X0708 D LIVE 0001541157 Akari Therapeutics Plc 401 EAST JACKSON STREET SUITE 3300 TAMPA FL FLORIDA 33602 (929) 274-7510 UNITED KINGDOM None Celsus Therapeutics Plc. Morria Biopharmaceuticals PLC Other Public Limited Company true Abizer Gaslightwala Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Executive Officer Director President and Chief Executive Officer Kameel Farag Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Executive Officer Interim Chief Financial Officer Rob Bazemore Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Hoyoung Huh Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Jim Neal Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Ray Prudo Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Samir Patel Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Sandip Patel Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Other Health Care Decline to Disclose 06b false 2026-05-20 false true true true American Depositary Shares (ADSs), each representing 80,000 Ordinary Shares false 0 Paulson Investment Company, LLC 000005670 None None 150 2nd Avenue, North Suite 1550 St. Petersburg FL FLORIDA 33701 AZ ARIZONA FL FLORIDA false 5500000 1833333 3666667 Offering of ADSs, Pre-Funded Warrants, Series H, I and J Warrants, each convertible into one ADS for $5,500,000. Approximately $1,833,333 raised to date. The issuance of Series Warrants are subject to shareholder approval. false 6 125000 0 Paulson is also entitled to a fee equal to 2.0% of the gross proceeds, a non-accountable expense of $15,000, and 117,647 Placement Agent ADSs. The issuance of the Placement Agent ADSs are subject to receipt of shareholder approval. 0 The Company intends to use the net proceeds for working capital and general corporate purposes. false Akari Therapeutics Plc /s/ Abizer Gaslightwala Abizer Gaslightwala Chief Executive Officer and President 2026-06-03